Smac mimetic-derived augmentation of chemotherapeutic response in experimental pancreatic cancer

BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) is highly resistant to conventional chemotherapy, in part due to the overexpression of inhibitors of apoptosis proteins (IAPs). Smac is an endogenous IAP-antagonist, which renders synthetic Smac mimetics attractive anticancer agents. We evaluated t...

Descripción completa

Detalles Bibliográficos
Autores principales: Awasthi, Niranjan, Kirane, Amanda, Schwarz, Margaret A, Toombs, Jason E, Brekken, Rolf A, Schwarz, Roderich E
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3034706/
https://www.ncbi.nlm.nih.gov/pubmed/21226944
http://dx.doi.org/10.1186/1471-2407-11-15

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3034706/
https://www.ncbi.nlm.nih.gov/pubmed/21226944
http://dx.doi.org/10.1186/1471-2407-11-15

Ejemplares similares